US EditionPublished • loading... • Updated
Akura Medical closes series C financing
Summary by Cardiovascular News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Cardiovascular NewsReposted by 
Interventional News
Interventional NewsAkura Medical closes series C financing
Katana thrombectomy system Akura Medical has secured a US$53 million first close in series C financing, with the funds to be used to support development activities for the Katana thrombectomy system and the NavIQ quantification software, alongside completion of enrolment in the QUADRA-PE clinical trial and regulatory submissions. The financing round was led by Qatar Investment Authority (QIA) with participation by current investors. Part of the …
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
